Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD

Abstract Introduction Despite significant progress observed in the treatment of atopic dermatitis (AD), a considerable number of patients with severe disease are undertreated and have inadequate symptom control. This may be due to several reasons, such as underestimation of the implications of the d...

Full description

Saved in:
Bibliographic Details
Main Authors: Pedro Mendes-Bastos, Elisavet Lazaridou, Tiago Torres, Charalampos Aggelakopoulos, Ioannis Katsantonis, Pantelis Aronis, Dimitrios Rigopoulos, Filomena Azevedo, Felicidade Santiago, Markos Papakonstantis, Paulo Varela, Vera S. G. Ribeiro, Aikaterini Kollia, Evaggelia Papadavid
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-04-01
Series:Dermatology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s13555-025-01414-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850270868575354880
author Pedro Mendes-Bastos
Elisavet Lazaridou
Tiago Torres
Charalampos Aggelakopoulos
Ioannis Katsantonis
Pantelis Aronis
Dimitrios Rigopoulos
Filomena Azevedo
Felicidade Santiago
Markos Papakonstantis
Paulo Varela
Vera S. G. Ribeiro
Aikaterini Kollia
Evaggelia Papadavid
author_facet Pedro Mendes-Bastos
Elisavet Lazaridou
Tiago Torres
Charalampos Aggelakopoulos
Ioannis Katsantonis
Pantelis Aronis
Dimitrios Rigopoulos
Filomena Azevedo
Felicidade Santiago
Markos Papakonstantis
Paulo Varela
Vera S. G. Ribeiro
Aikaterini Kollia
Evaggelia Papadavid
author_sort Pedro Mendes-Bastos
collection DOAJ
description Abstract Introduction Despite significant progress observed in the treatment of atopic dermatitis (AD), a considerable number of patients with severe disease are undertreated and have inadequate symptom control. This may be due to several reasons, such as underestimation of the implications of the disease on patients, families, and society, as well as inconsistent access to effective treatment. The multidimensional disease burden of AD includes other atopic comorbidities, sleep disturbance, and functional impairment and secondary consequences, including neuropsychiatric issues (anxiety and depression) and reduced health-related quality of life. Methods MEASURE-AD was a global, cross-sectional observational study in adolescents and adults with moderate-to-severe AD, conducted to describe disease burden, treatment patterns, and healthcare resource utilization. Results The results concerning patients from Portugal and Greece indicate moderate-to-severe disease for most of the population with frequent disease flares. The quality of life of both adolescents and adults was greatly affected, mainly owing to itch. One out of five patients perceived that their treatment was not effectively controlling AD. Disease resulted in important out-of-pocket expenses and loss of productivity. Conclusions Understanding and recognizing the complex burden of moderate-to-severe AD is required to encourage and guide changes in public policy for the effective management of patients.
format Article
id doaj-art-279510a74ca14057bddd29ca0d2e7db3
institution OA Journals
issn 2193-8210
2190-9172
language English
publishDate 2025-04-01
publisher Adis, Springer Healthcare
record_format Article
series Dermatology and Therapy
spelling doaj-art-279510a74ca14057bddd29ca0d2e7db32025-08-20T01:52:25ZengAdis, Springer HealthcareDermatology and Therapy2193-82102190-91722025-04-011561487150510.1007/s13555-025-01414-1Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-ADPedro Mendes-Bastos0Elisavet Lazaridou1Tiago Torres2Charalampos Aggelakopoulos3Ioannis Katsantonis4Pantelis Aronis5Dimitrios Rigopoulos6Filomena Azevedo7Felicidade Santiago8Markos Papakonstantis9Paulo Varela10Vera S. G. Ribeiro11Aikaterini Kollia12Evaggelia Papadavid13Dermatology Center, Hospital CUF Descobertas2nd Department of Dermatology-Venereology, Aristotle University School of Medicine, “Papageorgiou” General HospitalUnidade Local de Saúde de Santo António, Largo do Prof. Abel SalazarDermatology Department, Athens Naval HospitalDermatology Department, Tzaneio General HospitalClinic of Dermatology, Hellenic Airforce 251 General Hospital1st Department of Dermatology and Venereology, National and Kapodistrian University of Athens School of MedicineUnidade Local de Saúde de São João, Alameda Prof. Hernâni MonteiroUnidade Local de Saúde da Região de Leiria, Hospital de Santo André, R. de Santo AndréClinic of Dermatology, 401 General Military Hospital of AthensUnidade Local de Saúde deGaia e Espinho, R. Conceição FernandesAbbVie, Lda.; Estrada Alfragide 67 Alfrapark, Edifício DAbbVie Pharmaceuticals S.A2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, “Attikon” University General HospitalAbstract Introduction Despite significant progress observed in the treatment of atopic dermatitis (AD), a considerable number of patients with severe disease are undertreated and have inadequate symptom control. This may be due to several reasons, such as underestimation of the implications of the disease on patients, families, and society, as well as inconsistent access to effective treatment. The multidimensional disease burden of AD includes other atopic comorbidities, sleep disturbance, and functional impairment and secondary consequences, including neuropsychiatric issues (anxiety and depression) and reduced health-related quality of life. Methods MEASURE-AD was a global, cross-sectional observational study in adolescents and adults with moderate-to-severe AD, conducted to describe disease burden, treatment patterns, and healthcare resource utilization. Results The results concerning patients from Portugal and Greece indicate moderate-to-severe disease for most of the population with frequent disease flares. The quality of life of both adolescents and adults was greatly affected, mainly owing to itch. One out of five patients perceived that their treatment was not effectively controlling AD. Disease resulted in important out-of-pocket expenses and loss of productivity. Conclusions Understanding and recognizing the complex burden of moderate-to-severe AD is required to encourage and guide changes in public policy for the effective management of patients.https://doi.org/10.1007/s13555-025-01414-1Atopic dermatitisBurden of diseaseExpensesProductivityQuality of lifeSymptom control
spellingShingle Pedro Mendes-Bastos
Elisavet Lazaridou
Tiago Torres
Charalampos Aggelakopoulos
Ioannis Katsantonis
Pantelis Aronis
Dimitrios Rigopoulos
Filomena Azevedo
Felicidade Santiago
Markos Papakonstantis
Paulo Varela
Vera S. G. Ribeiro
Aikaterini Kollia
Evaggelia Papadavid
Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD
Dermatology and Therapy
Atopic dermatitis
Burden of disease
Expenses
Productivity
Quality of life
Symptom control
title Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD
title_full Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD
title_fullStr Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD
title_full_unstemmed Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD
title_short Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD
title_sort multidimensional burden of moderate to severe atopic dermatitis in adolescent and adult patients from portugal and greece results from the global cross sectional study measure ad
topic Atopic dermatitis
Burden of disease
Expenses
Productivity
Quality of life
Symptom control
url https://doi.org/10.1007/s13555-025-01414-1
work_keys_str_mv AT pedromendesbastos multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT elisavetlazaridou multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT tiagotorres multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT charalamposaggelakopoulos multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT ioanniskatsantonis multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT pantelisaronis multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT dimitriosrigopoulos multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT filomenaazevedo multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT felicidadesantiago multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT markospapakonstantis multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT paulovarela multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT verasgribeiro multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT aikaterinikollia multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread
AT evaggeliapapadavid multidimensionalburdenofmoderatetosevereatopicdermatitisinadolescentandadultpatientsfromportugalandgreeceresultsfromtheglobalcrosssectionalstudymeasuread